And two! The High Authority for Health (HAS) on Wednesday authorized the vaccination of 12-17 year olds with Moderna against the coronavirus. This is the second vaccine authorized in France for adolescents, after Pfizer. On Friday, the European Medicines Agency authorized the vaccination of adolescents with Moderna.
In early June, Moderna applied for marketing authorization in the European Union and Canada for its vaccine against Covid-19, Spikevax, which uses the same mRNA technology as that of the Pfizer alliance / BioNTech. The group said at the end of May that its remedy was “highly effective” in adolescents aged 12 to 17, according to the results of clinical trials on more than 3,700 participants of this age group in the United States. The serum produced in them an antibody response comparable to that seen in young adults aged 18 to 25 years.